Characteristics of AA amyloidosis patients in San Francisco

Hiba Lejmi, Kuang-Yu Jen, Jean L. Olson, Sam H. James, Ramin Sam

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

Background AA amyloidosis due to subcutaneous injection of drugs of abuse has been described in the USA, but all the existing literature is from more than 20 years ago. There is more recent literature from Europe. We have observed a high incidence of AA amyloidosis in the county hospital in San Francisco. Design Here, we describe 24 patients who had kidney biopsy-proven AA amyloidosis from our hospital from 1998 to 2013. All the patients were thought to have AA amyloidosis from skin popping of illicit drugs after having exhausted the intravenous route. These patients with biopsy-proven AA amyloidosis were analysed further. Results All patients were found to have hepatitis C infection, hypertension was not common, most had advanced kidney failure, and acidosis was common as was tubulointerstitial involvement on the kidney biopsy. Other organ involvement included hepatomegaly and splenomegaly in a number of patients; direct myocardial involvement was not seen, but pulmonary hypertension, history of deep vein thrombosis and pulmonary embolism were common. The prognosis of these patients was poor. The mortality rate approached 50% 1 year after biopsy, and most of the patient needed dialysis shortly after diagnosis. Cessation of drug use seemed beneficial but rarely achievable. Conclusion AA amyloidosis from skin popping is common in San Francisco. Most patients with renal involvement end up on dialysis, and mortality rates are exceedingly high.

Original languageEnglish (US)
Pages (from-to)308-313
Number of pages6
JournalNephrology
Volume21
Issue number4
DOIs
StatePublished - Apr 1 2016
Externally publishedYes

    Fingerprint

Keywords

  • AA amyloidosis
  • secondary amyloidosis
  • skin popping

ASJC Scopus subject areas

  • Nephrology

Cite this

Lejmi, H., Jen, K-Y., Olson, J. L., James, S. H., & Sam, R. (2016). Characteristics of AA amyloidosis patients in San Francisco. Nephrology, 21(4), 308-313. https://doi.org/10.1111/nep.12616